CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase II Study of sEphB4-HSA in Metastatic Castration-Resistant Prostate Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04033432
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:41.055203+00:00
Published At: 2022-04-27T00:00:00+00:00
Record Updated At: 2022-04-27
Results Posted At: 2022-04-27
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Castration Levels of Testosterone", "Castration-Resistant Prostate Carcinoma", "Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents", "Metastatic Prostate Adenocarcinoma", "Progressive Disease", "Prostate Carcinoma Metastatic in the Bone", "Prostate Carcinoma Metastatic in the Soft Tissue", "PSA Progression", "Stage IVB Prostate Cancer AJCC v8", "Testosterone Less Than 50 ng/dL"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2022-04-27"
protocolSection.identificationModule.nctId: "NCT04033432"
protocolSection.identificationModule.officialTitle: "A Phase II Study of sEphB4-HSA in Metastatic Castration-Resistant Prostate Cancer"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2022-04-27"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.